Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. M. PembrolizuMAb+Axitinib
USA. M. PembrolizuMAb+Axitinib's subsections
(*) EU Approval Date: 2019. 09.04
(*) JP Approval Date: 2019. 12.20
(*) USA Approval Date: 2019. 04.22
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.31.
TradeMark Axitinib
TradeMark Axitinib Web-Site
TradeMark PembrolizuMAb
TradeMark PembrolizuMAb Web-Site
USA. M. PembrolizuMAb+Axitinib's products
This section has no products